Company Filing History:
Years Active: 2000
Title: David Michael Evans - Innovator in Kininogen Inhibition
Introduction
David Michael Evans is a notable inventor based in Southampton, GB. He has made significant contributions to the field of biochemistry, particularly in the development of kininogen inhibitors. His innovative work has led to the creation of a patent that addresses important medical applications.
Latest Patents
David holds a patent for "Kininogen inhibitors - Kininogenase inhibiting peptides or peptide analogues with C-terminal related to agmatine or noragmatine." This patent represents a crucial advancement in the understanding and treatment of various conditions related to kininogen activity.
Career Highlights
David is currently associated with Feering B.V., where he continues to push the boundaries of research and innovation. His work at the company has been instrumental in developing new therapeutic strategies.
Collaborations
David has collaborated with notable colleagues, including Michael Szelke and David Michael Jones. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
David Michael Evans is a distinguished inventor whose work in kininogen inhibition has the potential to impact medical science significantly. His contributions through patents and collaborations highlight his commitment to innovation in the field.